iFluidics was incorporated in 2010 by the inventors, Frederic Bottausci and Igor Mezic, together with Caroline Cardonne, Jason Spievak, and Peter Strand.  A technological cornerstone of the iPlate Platform is low-volume electro-kinetic mixing: a 1536-well plate-based prototype system was recognized as an Innovation Award finalist at the 2008 Association for Laboratory Automation.  This prototype system’s mixing capability has been validated on many important classes of biochemical tests and has received strong interest from major pharmaceutical and biotech companies, and academic research labs.  

 

The company has since then focused on perfecting the technology and validating prototype systems with leading clinical laboratories; focusing on 96-well microplate, while also confirming capability in the 384- and 1536-well formats.  The company reorganized and expanded its leadership team in 2017; and has developed the software and hardware of the iPlate Platform and the captive consumable iPlates into a flexible and general purpose “market ready product” for the unregulated life sciences research market. 

 

Integrated Fluidics’ technology is protected by two issued patents.  The U. S. Patent Office has issued the foundational patent “Dynamic equilibrium separation, concentration, and mixing apparatus and methods” (US Patent 8,182,669), and “Small Volume Liquid Manipulation Method, Apparatus and Process” (US Patent 8,246,802).  Both of these patents can be licensed exclusively to Integrated Fluidics by the University of California, Santa Barbara (UCSB) upon negotiation. A summary of the  patents and the typical terms and conditions of the UCSB license are below.

​